|
Written by Webmaster
Friday, 06 August 2010 17:35
|
|
| Médimabs is proud to announce the licensing of two monoclonal antibodies against TC-PTP for immunomodulation research. These antibodies react against the N-terminal or the C-terminal portion of T-cell protein tyrosine phosphatase. |
